Show simple item record

dc.contributor.authorHortigüela, María J.
dc.contributor.authorLucie Aumailley, Lucie
dc.contributor.authorSrivastava, Akshay
dc.contributor.authorCunningham, Clare
dc.contributor.authorAnandakumar, Soshee
dc.contributor.authorRobin, Sylvain
dc.contributor.authorPandit, Abhay
dc.contributor.authorHu, Xuejun
dc.contributor.authorWall, Gerard
dc.date.accessioned2016-12-14T15:21:59Z
dc.date.available2016-12-14T15:21:59Z
dc.date.issued2015-08-18
dc.identifier.citationHortigüela, M. J., Aumailley, L., Srivastava, A., Cunningham, C., Anandakumar, S., Robin, S., Pandit, A., Hu, X., and Wall, J. G. (2015) Engineering recombinant antibodies for polymer biofunctionalization. Polym. Adv. Technol., 26: 1394–1401. doi: 10.1002/pat.3619.en_IE
dc.identifier.issn1099-1581
dc.identifier.urihttp://hdl.handle.net/10379/6246
dc.description.abstractThe attachment of recognition elements such as antibody fragments to polymeric substrates can be used to mediate cell- or protein-specific interactions. In this work, single-chain Fv (scFv) antibody fragments were isolated against two cell types of interest and expressed in an Escherichia coli expression platform. The scFvs were engineered at their C-terminus to incorporate a cysteine-containing linker, for reaction with maleimide-linked polymers, or a heptasaccharide glycan for complexation with surface amine moieties. Antigen binding of the modified scFvs was unchanged, and expression yields of the glyco-engineered scFvs were similar to the unmodified molecules, while cys-tagged scFv yields varied between scFv variants. Targeted immobilization of the scFvs via either modification resulted in three-to five-fold higher binding of ligands over adsorbed molecules. The study demonstrates a simple and efficient antibody engineering and modification approach for effective targeted immobilization on polymeric substrates. Copyright (C) 2015 John Wiley & Sons, Ltd.en_IE
dc.description.sponsorshipThis work was supported by Irish Research Council (IRC) grantPD/2010/1689 (MJH), Science Foundation Ireland Grant 07/SRC/B1163 (CC, AS), Enterprise Ireland Science and TechnologyAgency Grant PC/2007/021 (SR) and European Union “EPICstent”Project Grant FP7-PEOPLE-2012-IAPP-324514 (SA).en_IE
dc.formatapplication/pdfen_IE
dc.language.isoenen_IE
dc.publisherWileyen_IE
dc.relation.ispartofPolymers For Advanced Technologiesen
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/ie/
dc.subjectBiomedical engineeringen_IE
dc.subjectRecombinant proteinen_IE
dc.subjectAntibody fragmenten_IE
dc.subjectImmobilizationen_IE
dc.subjectBiofunctionalizationen_IE
dc.subjectEscherichia colien_IE
dc.subjectBiomedical appliocationsen_IE
dc.subjectDomoic aciden_IE
dc.subjectAffinity maturationen_IE
dc.subjectMonoclonal antibodyen_IE
dc.subjectVariable domainsen_IE
dc.subjectIn vitroen_IE
dc.subjectFragmenten_IE
dc.subjectBindingen_IE
dc.titleEngineering recombinant antibodies for polymer biofunctionalizationen_IE
dc.typeArticleen_IE
dc.date.updated2016-12-14T15:05:47Z
dc.identifier.doi10.1002/pat.3619
dc.local.publishedsourcehttp:dx.doi.org/10.1002/pat.3619en_IE
dc.description.peer-reviewedpeer-reviewed
dc.contributor.funder|~|
dc.internal.rssid10558974
dc.local.contactAbhay Shashikant Pandit, Curam, Biomedical Sciences, Nui Galway. 2758 Email: abhay.pandit@oegaillimh.ie
dc.local.copyrightcheckedNo
dc.local.versionACCEPTED
nui.item.downloads427


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland